🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study evaluating the safety, preliminary efficacy and pharmacokinetics of...
Status
Terminated
Location
HOPITAL JEAN MINJOZ; Oncologie
Start Date
2020-07-09
Trial ID
NCT04404140
Treatments Being Tested
This is a Phase I Clinical Trial to Evaluate the Safety, Tolerability and P...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2022-06-22
Trial ID
NCT05396391
Treatments Being Tested
The purpose of this study is to find the safest and most effective dose for...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2018-04-26
Trial ID
NCT03520504
Treatments Being Tested
This is a phase Ib/II, randomized, double-blind, placebo-controlled, parall...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05525715
Treatments Being Tested
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-01-29
Trial ID
NCT07208149
Treatments Being Tested
Brief Description: This study is designed to evaluate the safety and toler...
Status
Unknown
Location
Cancer Institute and Hospital,Chinese Academy of Medical Sciences
Start Date
2013-04
Trial ID
NCT01931943
Treatments Being Tested
This is a follow-up study to assess safety and clinical activity of continu...
Status
Completed
Location
Studienzentrum der PROSENEX, AmbulatoriumsbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt
Start Date
2016-02-02
Trial ID
NCT02618941
Treatments Being Tested
The purpose of this open label study is to evaluate the safety, tolerabilit...
Status
Terminated
Location
Research Site
Start Date
2012-02
Trial ID
NCT01489722
Treatments Being Tested
This is an open, multi-cohort clinical study. The first phase is a dose esc...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2024-01
Trial ID
NCT06211751
Treatments Being Tested
This study aims to evaluate the safety and efficacy of Ivonescimab, a bispe...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2025-02-08
Trial ID
NCT06844422
Treatments Being Tested